Results 351 to 360 of about 1,334,419 (369)

Activation of natural killer cells with interleukin 2 (IL‐2) and IL‐12 increases perforin binding and subsequent lysis of tumour cells

British Journal of Haematology, 2001
Christof Lehmann, M. Zeis, L. Uharek
semanticscholar   +1 more source

Interleukin 2 (IL-2)

2009
openaire   +2 more sources

Tumour regression after intralesional injection of interleukin 2 (IL‐2) in bladder cancer. Preliminary report

International Journal of Cancer, 1984
G. Pizza, G. Severini, D. Menniti, C. de Vinci, Francesco Corrado   +4 more
semanticscholar   +1 more source

The regulatory, inflammatory, and T cell programming roles of interleukin-2 (IL-2).

Journal of Autoimmunity, 2008
Ruth Y. Lan, C. Selmi, M. Gershwin
semanticscholar   +1 more source

[Interleukin-2 (IL-2) and IL-2 receptor].

Nihon rinsho. Japanese journal of clinical medicine, 2000
T, Nishimura, T, Taniyama
openaire   +1 more source

Lack of interleukin‐2 (IL‐2) expression and selective expression of IL‐10 mRNA in human renal cell carcinoma

International Journal of Cancer, 1995
H. Nakagomi, P. Pisa, E. Pisa, Y. Yamamoto, E. Halapi, K. Backlin, C. Juhlin, R. Kiessling   +7 more
semanticscholar   +1 more source

Interleukin‐2 (IL-2)

2008
openaire   +1 more source

Induction of circulating tumor necrosis factor (TNFα) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patients

Journal of Clinical Immunology, 1988
J. Mier, G. Vachino, J. Meer, R. Numerof, S. Adams, J. Cannon, H. Bernheim, M. Atkins, D. Parkinson, C. Dinarello   +9 more
semanticscholar   +1 more source

Interleukin-2 (IL-2)

2016
openaire   +1 more source

Role of Zinc in Interleukin 2 (IL‐2)‐Mediated T‐Cell Activation

Scandinavian Journal of Immunology, 1990
Y. Tanaka, S. Shiozawa, I. Morimoto, T. Fujita   +3 more
semanticscholar   +1 more source